Evidence map›Paper›PMID 38610138›Full record

ArticleHealthcare (Basel, Switzerland)2024

Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs.

Rebecca G Kim, Claire McDonell, Jeff McKinney, Lisa Catalli, Jennifer C Price, Meghan D Morris

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03987503 (The No One Waits Study), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03987503 phase4completednot on this map

The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study

TypeinterventionalSponsorUniversity of California, San FranciscoRan2020 to 2022Enrolled87ConditionsHepatitis C, ChronicArmsEpclusa (SOF/VEL), Standard of care, Fibroscan® 430 Mini Plus
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rebecca G KimDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT 84132, USA.ORCID 0000-0001-7965-5760
Claire McDonellDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0009-0005-7116-3346
Jeff McKinneyDepartment of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, CA 94143, USA.
Lisa CatalliDepartment of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-3952-5392
Jennifer C PriceDepartment of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, CA 94143, USA.
Meghan D MorrisDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158, USA.
University of California, San Francisco · USUniversity of Utah · US

Funding

Gilead Sciences (United States) IN-US-342-5516
6 · The paper itself

Abstract

backgroundTelemedicine offers the opportunity to provide clinical services remotely, thereby bridging geographic distances for people engaged in the medical system. Following the COVID-19 pandemic, the widespread adoption of telemedicine in clinical practices has persisted, highlighting its continued relevance for post-pandemic healthcare. Little is known about telemedicine use among people from socially marginalized groups.

methodsThe No One Waits (NOW) Study is a single-arm clinical trial measuring the acceptability, feasibility, and safety of an urban point-of-diagnosis hepatitis C (HCV) treatment initiation model delivered in a non-clinical community setting. Participants enrolled in the NOW Study are recruited via street outreach targeting people experiencing homelessness and injecting drugs. Throughout the NOW Study, clinical care is delivered through a novel staff-facilitated telemedicine model that not only addresses geographic and transportation barriers, but also technology and medical mistrust, barriers often unique to this population. While clinicians provide high-quality specialty practice-based care via telemedicine, on-site staff provide technical support, aid in communication and rapport, and review the clinicians' instructions and next steps with participants following the visits. Research questionnaires collect information on participants' experience with and perceptions of telemedicine (a) prior to treatment initiation and (b) at treatment completion. DISCUSSION: For people from socially marginalized groups with HCV infection, creative person-centered care approaches are necessary to diagnose, treat, and cure HCV. Although non-clinical, community-based staff-facilitated telemedicine requires additional resources compared to standard-of-care telemedicine, it could expand the reach and offer a valuable entrance into technology-delivered care for socially marginalized groups.

trial registrationNCT03987503.

Indexed as

community-based careHCV treatmentmarginalized populationstelehealth

Identifiers

PMID38610138
PMCPMC11012066
OpenAlexW4393140306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.